
|Articles|May 1, 2005
- Volume 0 0
Yoga May Relieve Insomnia
Advertisement
A preliminary study from Brigham and Women's Hospital, Harvard Medical School, showed thatyoga may help individuals with insomnia. During the study, participants with chronic insomnia didyoga daily. They also kept sleep—wake diaries over a 2-week baseline period and a 8-week subsequentintervention. A comparison of pretreatment and end treatment found that 20 participantsexhibited major improvements in sleep efficiency, total sleep time, total wake time, sleep onsetlatency, and wake time after sleep onset.
Articles in this issue
over 21 years ago
Top 200 Prescription Drugs of 2004over 21 years ago
New Drugs of 2004over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Avastin Decreases Lung Cancer Patients' Mortalityover 21 years ago
Simvastatin Improves Mortality of Heart Failure Patientsover 21 years ago
Pharma Companies Developing Antismoking Drugsover 21 years ago
Handbook Disclaimers Permit Dismissal of Pharmacistover 21 years ago
Annual Eye Exams Unnecessary for Someover 21 years ago
Safe Options for Needle Disposalover 21 years ago
Prevention Can Save $2.5 Billion AnnuallyAdvertisement
Related to this article

Inconsistent state immunization laws complicate pharmacy operations and limit patient access.

OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.

The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.

Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.

Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.

Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
5

